Navigation path

Projets du 5e PC

Liste des projets du 5e PC classés par acronyme
(description des projets uniquement disponible en anglais)

pas d'acronyme Collaboration on Vaginal Microbicides Development for the Prevention of HIV Transmission
ACCELTB EU Accelerated Action Against Tuberculosis: The Agenda for Africa
ADMALI Adhesive Interactions in Malaria: New Targets for Intervention
AFTBVAC Development of a Tuberculosis Vaccine in Africa
AMVTN/AMANET African Malaria Vaccine Testing Network
AMVTNETHIC AMVTN Workshops on the Molecular Biology and Immunology of Malaria Vaccines
ARTESUNATE Research and Development of Rectal Artesunate
ATTMAL New Genetic Technologies: Applications to Generate Attenuated Malaria Vaccines
BCGNSE BCG Vaccination and Childhood Morbidity and Mortality: Interventions with Possible Implications for Immunisation Policy in Developing Countries
Bridging gaps Bridging the Gaps Between Public and Traditional Healthcare Sectors – Testing a Model to Improve Quality of STI/HIV/AIDS Care in sub-Saharan Africa
CASA Optimising the Use of the Syndromic Approach for STI Management and Prevention in Resource Poor Settings
CASCADE Concerted Action on SeroConversion to AIDS and Death in Europe
CASCADE Virology Virological Characterisation of Primary HIV Infection in the Concerted Action on SeroConversion to AIDS and Death in Europe
CELL CYCLE & DORMANCY IN TB Regulation of the Cell Cycle and Dormancy in Mycobacterium Tuberculosis
China-HIV-VacIII Phase I/II clinical testing of Clade C-based HIV-1 Candidate Vaccines in China
COCONUTKIT Project to coordinate the write up of a protocol for a clinical trial aimed at shortening treatment for tuberculosis
CTL and HIV- super Infection CTL-Mediated Protection from HIV-1 Infection in a High-Risk Cohort in Tanzania: Persistent Seronegativity, Persistent Single-Subtype Infection, and Cross-Subtype Superinfection
DETEC SIV/HIV Vaccines: Detecting Efficacy and Explaining Inefficacy
DISSARM Development of Integrable Sensors for Screening of Antibiotic Resistance in Mycobacterium
DOT AFRICAN TRIAL A Multicentre Randomised Trial of Directly Observed Treatment for Tuberculosis Patients in Sub-Saharan Africa
ECS European Collaborative Study on Pregnant HIV Infected Women and Their Children
EDCTP European and Developing Countries Clinical Trials Programme
EMLI Phase-I and II Trials of the Malaria Pre-Erythrocytic Vaccine LSA-3 and Refinement  of Measurable Outcomes
EMVI European Malaria Vaccine Initiative
EMVI-TRIAL-PROTOCOLS European Malaria Vaccine Clinical Trial Protocols
ENVEP European Network for Vaccine Evaluation in Primates: Combined Vector Immunisation for AIDS Vaccine Development
EUROMALVAC1 A European Malaria Vaccine Development Consortium
EUROMALVAC-2 The Second Phase of a European Malaria Vaccine Development Consortium
EuroSIDA The EuroSIDA network 2000-200: Clinical and Virological Outcome of European Patients Infected with HIV
EUROVAC I European Vaccine Effort Against HIV/AIDS
EUROVAC II European Vaccine Effort Against HIV/AIDS-II
EuroVac-III European Vaccine Effort Against HIV/AIDS – III
EVA Programme EVA (European Vaccine Against Aids) Centralised Facility For Aids Reagents
FACT Development of Oral Fixed Dose Artesunate-Based Combinations for the Treatment of Uncomplicated Malaria
HIV COM THER Development and Testing of a Combined Anti-Retroviral, Immune, and Gene Therapy for Treatment of HIV Patients
HIV PR INHIBITORS Rational Approaches Towards Understanding and Overcoming HIV Protease Inhibitor Resistance
HIV RESISTANCE New Tools to Investigate and Suppress HIV Drug Resistance
HIV-1 MTCT International Network on HIV-1 Mother-to-Child Transmission: Developing Integration of Healthcare Programmes, Clinical, Social and Basic Research
HIVIS Study of Immunogenicity of DNA HIV-1 env, gag and pol Plasmid Vaccines Boosted with MVA in Tanzania: HIV Vaccine Immunogenicity Study
HIVPRIMEBOOST THERVAC Improvement of a Therapeutic Adjuvanted Protein HIV Vaccine by Combination with DNA Immunisation in a Prime-Boost Regimen
HIV-superinfections Behavioural, Immunological and Virologic Correlates of HIV-1 Superinfection (HIV+ vs HIV++) in Rural Tanzania
ISCOTB Novel Approaches to Induce Mucosal Immunity Against TB Using the Combined Adjuvant Strategy of CTA-1 and ISCOMS
LAMNET New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa
LONG-DRUG Characterisation of Mycobacterium Tuberculosis Populations During Infection: A  Longitudinal Study on Drug Resistance Development
MALCROSS Genetic Analysis of the Chloroquine Drug Resistance and the Accelerated-Resistance-to Multiple Drugs Phenotypes in the Human Malarial Parasite Plasmodium Falciparum
MALTRANS Project Interruption of Malaria Transmission Vaccine Strategies
MALVECASIA Monitoring Insecticide Resistance and Mapping Malaria Vectors in Southeast Asia : A Prerequisite for Sustainable Malaria Vector Control
MAMOP Improving the Management of Childhood Malaria: An Experiment to Bridge the Gap Between Mothers and Healthcare Providers
MICROBICIDES 2002 Conference ‘Microbicides 2002’ Antwerp, 12-15 May 2002
Mol.Epidemology TB New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis
MUCOSAL TB VACCINE Role of Mucosal Immunity for Protection against Tuberculosis
MUVADEN Mucosal Vaccines Against Human and Simian Immunodeficiency Viruses Based on Dendritic Cells
NEMLAR AMVTN Seminar on Health Research Ethics in Africa
NEW ANTIMALARIALS Clinical and Pre-Clinical Evaluation of Fosmidomycin and its Derivates as Antimalarial Drugs
NEW ANTIMYCOBACTERIALS Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Drugs Against Tuberculosis
New cAMP antagonists Development of Antagonists that Disrupt the Hyperactivated cAMP Signalling Pathway in Immunodeficiencies as Immunostimulatory Therapy
NOVEL ANTIMALARIALS Malarial Chemotherapy Targeting Plasmodial Phospholipid Biosynthesis: Implementation of a Pro-drug Strategy for Orally Active Compounds
OFLOTUB A Multicentre, Randomised, Control Trial of Ofloxacine-Containing, Short-Course Regimen for the Treatment of Pulmonary Tuberculosis
ORISS Project Operational Research in STI and Related Services for Women in High-Risk Situations in Cambodia and Thailand
PAMVAC The Development of Vaccine Against Pregnancy-Associated Malaria - PAMVAC (Pregnancy-Associated Malaria Vaccine)
PARASAC Organisation of an International Conference: ‘Moving targets - Parasites, Resistance and Access to Drugs’ from 4-6 December 2000
PENTA Paediatric European Network for the Treatment of AIDS
PERSISTENT TB Novel Drug Targets Specific to Persistent (Latent) Tuberculosis Infection:  Crystallisation, Structure Determination and Functional Studies
PREMA-EU A Cost-Shared Concerted Action on Malaria and Anaemia Control in Pregnant Women
PVPFDHFR Dihydrofolate Reductase-Thymidylate Synthase from Plasmodium Vivax and P. falciparum as Targets for Antimalarial Chemotherapy
RESMALCHIP Development of a Malaria-Resistant DNA Chip as a Public Health Tool for the Management of Plasmodium Falciparum Malaria Drug Resistance
SATZ Promoting Sexual and Reproductive Health. School-Based HIV/AIDS Prevention in Sub-Saharan Africa
SN-TB DIAGNOSIS A System Approach to Optimising Diagnosis of Smear-Negative Tuberculosis in High and Low Prevalence Countries of South America
SPREAD Strategy to Control SPREAD of HIV Drug Resistance
TARGETING NEF The HIV-1 Pathogenicity Factor Nef as a Novel Therapeutic Target
TB prevention cluster New Strategies for Treatment and Prevention of Mycobacterial Diseases
TB VACCINE CLUSTER A Cluster for Tuberculosis Vaccine Development
THERAVAC Evaluation of a Therapeutic Vaccination Strategy for HIV-1 Infection TheraVac
Upgrade Diagno MDR-TB Improved Diagnosis, Drug Resistance Detection and Control of Tuberculosis in Latin America
VACSEL Longitudinal Study of Correlates of Immunity to Tuberculosis in Exposed Individuals
VACSIS Host-Parasite Relationship in Susceptibility to Tuberculosis
VIRIMAL Structure, Function and Vaccine Potential of the Vir Multigene Family in Malaria
VIRULENCE HIV-1 Reverse Transcriptase Inhibitor Resistance and Its Consequences for Viral Virulence
X-TB Structural and Functional Genomics of Mycobacterium Tuberculosis